Bilwadi Leha

Names and identification

Language	Name
English	Bilwadi Leha

Where is it described in the classical texts?

Bhaishajya Ratnavali; Sharangadhara Samhita; Kerala Ayurveda tradition (medieval period, 8th-12th century CE); various classical compendia for Atisara and Grahani

How does it work?

• Bilwa (Aegle marmelos) provides potent anti-diarrheal action through tannin-mediated astringent effect on intestinal mucosa
• Musta (Cyperus rotundus) provides Grahi (absorbent) and Deepana (digestive stimulant) properties, normalizing stool consistency
• Trikatu stimulates Agni (digestive fire), correcting Mandagni (weak digestion) that underlies IBS pathogenesis in Ayurveda
• Carminative spices (cumin, coriander, cardamom, caraway) reduce intestinal gas, bloating, and abdominal spasm
• Jaggery base provides prebiotic support and mild laxative action, balancing the astringent herbs for normalized bowel function

Which traditional uses are supported by research?

• Grahani (IBS): clinical trial validates 67-100% improvement across all IBS symptoms including pain, bloating, diarrhea, and mucus passage
• Atisara (diarrhea): anti-diarrheal action of Bilwa validated pharmacologically through astringent and antimicrobial mechanisms
• Pravahika (dysentery): traditional use supported by antimicrobial and intestinal mucosal protective properties of Bael
• Agnimandya (digestive weakness): Trikatu and carminative spices confirmed to enhance digestive enzyme activity and reduce flatulence

What do recent clinical trials show?

• Tiwari R, Pandya DH, Baghel MS 2013. Clinical evaluation of Bilvadileha in the management of irritable bowel syndrome. Ayu. PMID 24696573 · doi:10.4103/0974-8520.127717
  46 IBS patients treated for 12 weeks showed 67.09% improvement in abdominal pain, 100% resolution of bloating, 86.96% improvement in IBS-D, 100% resolution of mucus passage, and 97.50% improvement in urgency

2 further claims previously listed here could not be traced to a published paper and have been removed. Classical formulations are researched largely in journals that PubMed does not index, so an absence here reflects the reach of the index rather than the state of the evidence.

Recent safety updates

• Clinical trial in 46 IBS patients over 12 weeks showed no serious adverse effects at recommended doses
• Excess consumption may cause burning sensation, hot flashes, heartburn, or constipation; dose-dependent effects
• Some reports of itching and burning sensation may be attributable to low-quality brands rather than the formulation itself

What is it made of?

Key Active Markers

• Derived from constituent herbs (see individual herb profiles)
• Standardized on primary bioactive markers

Analytical Methods: HPLC fingerprinting, TLC (identity), LC-MS/MS (marker quantification)

Dosage forms and preparation

Dosage Forms: Avaleha/Leha (semi-solid confection), Granules (modern), Capsules (modern)

Standard Dosage: 6-12 g twice daily, as per AFI Part I

Bioavailability: Avaleha base with sugar and ghee enhances absorption of marmelosin and other coumarins. Semi-solid matrix provides sustained-release properties. Honey (added when cool) provides enzymatic bioenhancement and preservative action.

Optimal Timing: After meals or between meals, twice daily, for chronic diarrhea and IBS-type conditions

Shelf Life: 2 years from date of manufacture as per ASU guidelines for Avaleha preparations

Storage: Store in wide-mouth glass or food-grade HDPE jars with airtight lids in a cool, dry place. Temperature not exceeding 25°C. Protect from moisture.

Marker Compounds: Marmelosin, Marmelide, Aegelin, Skimmianine, Umbelliferone

Quality Parameters: Total solids (minimum 65%), pH, moisture content (<25%), total sugar, total fat, ash value, marmelosin content from Bilwa by HPLC, microbial limits, heavy metals, HPTLC fingerprint, organoleptic evaluation

Vehicle (Anupana): Warm water or buttermilk

Synergistic Combinations

• Kutajarishta
• Gangadhara Churna
• Bilwa Churna
• Dadimadi Ghrita|Dadimadi Ghrita